Mexico Computed Tomography Market Size
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Market Size (2024) | USD 159.35 Million |
Market Size (2029) | USD 215.78 Million |
CAGR (2024 - 2029) | 6.25 % |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Mexico Computed Tomography Market Analysis
The Mexico Computed Tomography Market size is estimated at USD 159.35 million in 2024, and is expected to reach USD 215.78 million by 2029, growing at a CAGR of 6.25% during the forecast period (2024-2029).
The COVID-19 pandemic resulted in lockdowns in Mexico, due to which hospitals were not able to operate at full capacity. Many clinical studies were canceled, as most imaging treatments were delayed, and all the conventional imaging studies CT scans were canceled. According to the circumstances in various regions of the country in March 2020, several appointments were rescheduled or canceled since imaging treatments were seen as elective treatments. The quantity of computed tomography scans reduced as a result of movement restrictions and social distance norms. Global Citizen Organization records show that the COVID-19 pandemic delayed Mexico's already meager testing in March 2021. In 2020 compared to 2019, there were fewer diagnoses because of the pandemic's strain on the healthcare system, which decreased by more than half. Data from the Organization for Economic Co-operation and Development (OECD) show that there were 2.1 fewer medical consultations per person in 2020 than there were in 2019, a decline from 2.3 in 2019. The market for computed tomography in Mexico was significantly damaged by the aforementioned issues. The market is reverting to pre-pandemic levels as COVID-19 instances decline, but it will take a long time to finish all the computed tomography procedures that were put off. Thus, the market will keep growing in the long term.
The increasing frequency of chronic diseases including cancer, diabetes, neurological disorders, etc. is what drives the computed tomography market in Mexico. The market for the nation is additionally fueled by the expanding technological developments in the relevant markets, expanding R&D activities, increasing investments, and expanding product launches. Mexico had 195,449 new cases of cancer in 2020, and GLOBOCAN 2020 projects that this figure will rise to 323,432 cases of cancer by 2040. The country's CT scanner market will be driven by the anticipated increase in cancer cases because CT scanners are used to diagnose different types of cancer. Thus, during the projection period, the market under study is anticipated to have significant growth. Mexico is one of the 29 countries in the IDF North America and Caribbean area where adults are more likely to have diabetes than non-diabetics (15.2%), with 12,805,200 cases overall in the nation. Diabetes will likely cause more cancer cases in the nation, which is expected to raise demand for the product being studied. Another factor boosting the growth of the computed tomography market for neurology applications is the rising prevalence of epilepsy in Mexico. The prevalence of epilepsy was higher in developing nations, including Mexico, in 2020, according to Anales Médicos de la Asociación Médica del Centro Médico ABC. According to the same report, Mexico has epilepsy prevalence rates ranging from 3.9 to 42.2 per 1,000 people. The usage of computed tomography for diagnostic brain imaging will rise along with the prevalence of epilepsy cases in Mexico. Consequently, the market under study will grow. Similar to this, a study conducted in August 2021 at the Centro de Investigación in Computación, Instituto Politécnico Nacional, Mexico, by Solorio-Ramrez et al. found that CT images are the most frequently used for the diagnosis of cerebral haemorrhages due to their high quality. The section is projected to grow as a result of such studies on the application of computed tomography for neurological illnesses. Thus, the abovementioned factors are expected to increase the market growth.
The high cost of equipment and CT scan procedures, the absence of adequate reimbursement, the strict regulatory clearance processes, and these factors are anticipated to restrain market expansion in Mexico.
Mexico Computed Tomography Market Trends
This section covers the major market trends shaping the Mexico Computed Tomography Market according to our research experts:
Oncology Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Factors that are leading to the growth of this segment include the high burden of cancer types in the Mexican population, the advantages of computed tomography systems over conventional computed tomography, and the increase in strategic initiatives by major companies to use computed tomography in diagnosing cancer. Mexico had 195,449 new cases of cancer in 2020, and GLOBOCAN 2020 projects that this figure will rise to 323,432 cases of cancer by 2040. The country's CT scanner market will be driven by the anticipated increase in cancer cases because CT scanners are used to diagnose different types of cancer. Thus, during the projection period, the market under study is anticipated to have significant growth. According to a report written by Yanin Chávarri-Guerra and released in September 2020, cancer-related mortality and the number of newly diagnosed cases of the disease are increasing in Mexico as well as other low- and middle-income nations. For Mexicans, cancer is the third most common cause of death, with lung, stomach, liver, prostate, and breast cancers being the most common types. Several government organizations in Mexico offer financial aid to those with cancer, notably the Instituto de Salud para el Bienestar (INSABI) for those without insurance. A number of non-governmental organisations also provide various resources, including SALVATi AC, Unidos, Fundación Teresa de Jess, Fundación Rebecca de Alba A.C., Fundación ALMA, and many others. Such programmes may motivate people to get regular cancer screenings. For the diagnosis of cancer, computed tomography is a crucial imaging method. Increased cancer testing could spur market expansion. Many businesses are releasing new items and increasing their presence in the nation. For instance, to raise the standard of treatment in Mexico, 630 Nanox.ARC units were deployed there in September 2020 thanks to an exclusive distribution deal between Nanox and SPI Medical. This change is anticipated to improve orthopaedic care at the hospital and accelerate market expansion. Consequently, it is anticipated that the aforementioned factors will further enhance market expansion in this sector.
Mexico Computed Tomography Industry Overview
Mexico computed tomography market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are Carestream Health, Dentsply Sirona Inc., GE Healthcare, Planmeca Group (Planmed OY), and Koninklijke Philips NV among others.
Mexico Computed Tomography Market Leaders
-
Carestream Health
-
GE Healthcare
-
Planmeca Group (Planmed OY)
-
Koninklijke Philips NV
-
Dentsply Sirona Inc.
*Disclaimer: Major Players sorted in no particular order
Mexico Computed Tomography Market News
- In September 2020, To raise the level of healthcare for Mexicans, Nanox and SPI Medical announced an exclusive distribution agreement for the deployment of 630 Nanox.ARC devices in Mexico.
- In February 2020, S. Scott Obenshain, a pediatrician at the University of Mexico, and Barry Ramo, a cardiologist in Albuquerque, published a study in the American Journal of Medicine. According to the study, finding calcium deposits that act as markers for the artery-clogging cholesterol plaques that might cause a heart attack is essentially a CT scan.
Mexico Computed Tomography Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Chronic Diseases
- 4.2.2 Rising Geriatric Population
- 4.2.3 Increasing Technological Advancements
-
4.3 Market Restraints
- 4.3.1 Lack Of Proper Reimbursement And Stringent Regulatory Approval Procedures
- 4.3.2 High Cost of Equipment
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Type
- 5.1.1 Low Slice
- 5.1.2 Medium Slice
- 5.1.3 High Slice
-
5.2 By Application
- 5.2.1 Oncology
- 5.2.2 Neurology
- 5.2.3 Cardiovascular
- 5.2.4 Musculoskeletal
- 5.2.5 Other Applications
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Diagnostic Centers
- 5.3.3 Other End Users
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Carestream Health
- 6.1.2 Canon Medical Systems Corporation (Toshiba Corporation)
- 6.1.3 Dentsply Sirona
- 6.1.4 GE Healthcare
- 6.1.5 Neusoft Medical Systems Co. Ltd
- 6.1.6 Planmeca Group (Planmed OY)
- 6.1.7 Koninklijke Philips NV
- 6.1.8 Samsung Electronics Co. Ltd (Samsung Medison)
- 6.1.9 Siemens Healthineers AG
- 6.1.10 J. Morita Corporation
- 6.1.11 Vatech Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityMexico Computed Tomography Industry Segmentation
As per the scope of the report, computed tomography (CT), also known as computerized axial tomography (CAT) scanning, is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images or scans of areas inside the body. It is primarily used in cancer diagnosis. Mexico Computed Tomography Market is segmented by Type (Low Slice, Medium Slice, and High Slice), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), and End User (Hospitals, Diagnostic Centers, and Other End Users). The report offers the value (in USD million) for all the above segments.
By Type | Low Slice |
Medium Slice | |
High Slice | |
By Application | Oncology |
Neurology | |
Cardiovascular | |
Musculoskeletal | |
Other Applications | |
By End User | Hospitals |
Diagnostic Centers | |
Other End Users |
Mexico Computed Tomography Market Research FAQs
How big is the Mexico Computed Tomography Market?
The Mexico Computed Tomography Market size is expected to reach USD 159.35 million in 2024 and grow at a CAGR of 6.25% to reach USD 215.78 million by 2029.
What is the current Mexico Computed Tomography Market size?
In 2024, the Mexico Computed Tomography Market size is expected to reach USD 159.35 million.
Who are the key players in Mexico Computed Tomography Market?
Carestream Health, GE Healthcare, Planmeca Group (Planmed OY), Koninklijke Philips NV and Dentsply Sirona Inc. are the major companies operating in the Mexico Computed Tomography Market.
What years does this Mexico Computed Tomography Market cover, and what was the market size in 2023?
In 2023, the Mexico Computed Tomography Market size was estimated at USD 149.98 million. The report covers the Mexico Computed Tomography Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Mexico Computed Tomography Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Mexico Computed Tomography Industry Report
Statistics for the 2024 Mexico Computed Tomography market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Mexico Computed Tomography analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.